Influence of GDM Diagnosis and Treatment on Weight Gain, Dietary Intake and Physical Activity in Pregnant Women with Obesity: Secondary Analysis of the UPBEAT Study.

La'Shay Atakora, Lucilla Poston, Louise Hayes, Angela C Flynn, Sara L White

Journal: Nutrients 2020;12(2):359

PMID: 32019123

Plain Language Summary

plain language summary logo

Obesity during pregnancy increases the risk of development of gestational diabetes (GDM), which can develop into type 2 diabetes postnatally. The UK has guidelines on diet and exercise in place following a positive result for GDM, however it is unclear how results from a GDM test may affect behaviours and weight gain in women with obesity during pregnancy. This secondary analysis of a randomised control trial; the UK pregnancies better eating and activity trial (UPBEAT), aimed to assess how a negative or positive diagnosis of GDM affects the diet, physical activity levels and weight gain of pregnant women with obesity. 1031 pregnant women who were positively and negatively diagnosed with GDM were randomly split into two groups for eight weeks. The intervention group received additional appointments with a health coach as well as regular antenatal appointments. The results showed that women who received a negative result to GDM gained significantly more weight than those with a positive diagnosis regardless of which treatment group they were allocated. GDM status also affected dietary intake, however no changes in amount of physical activity were seen with either diagnosis. It was concluded that pregnant women with obesity gained more weight if they received a negative result to GDM and a positive GDM result is associated with lower weight gain and dietary changes. This highlights the need for additional diet and weight gain strategies for pregnant women with obesity who return a negative GDM result. Clinicians could use this study to stress the importance of healthy eating and exercise to pregnant women with obesity, even if a negative GDM test is received.

Abstract

Obesity during pregnancy is associated with the development of gestational diabetes (GDM). This study aimed to assess if the result of an oral glucose tolerance test (OGTT) for GDM influences health (diet and physical activity) behaviours of pregnant women with obesity. In total, 1031 women who participated in the UK Pregnancies Better Eating and Activity Trial (UPBEAT) of a lifestyle intervention from early pregnancy were included. Changes in weight gain, dietary intake and physical activity following an OGTT undertaken between 27 and 28 weeks' and 34 and 36 weeks' gestation were examined using linear regression with appropriate adjustment for confounders. Obese women without GDM (IADPSG criteria) gained 1.9 kg (95% CI -2.2, -1.5, < 0.001) more weight than women with GDM. Women with GDM demonstrated greater reductions in energy (-142kcal, 95%CI -242.2, -41.9, = 0.006), carbohydrate intake (-1.5%E 95%CI -2.8, -0.3, = 0.016) and glycaemic load (-15.2, 95%CI -23.6, -6.7, < 0.001) and a greater increase in protein intake (2%E, 95%CI 1.3, 2.7, < 0.001), compared to women without GDM. Trial intervention allocation did not influence any associations observed. The findings emphasise the need for strategies to optimise the health behaviours of pregnant women with obesity, following a negative OGTT for GDM.

Address: London School of Hygiene and Tropical Medicine, London, WC1E 7HT, UK.; Department of Women and Children's Health, King's College London, London, SE1 7EH, UK.; Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, NE2 4AX, UK.; Guy's and St Thomas' NHS Foundation Trust, London, SE1 7EH, UK.

Patient Centred Factor

Jadad Score

Allocation Concealment

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.